[Efficacy of an aldosterone receptor blocker eplerenone in high risk survivors of acute myocardial infarction with signs of heart failure: results of EPHESUS].
Trifonov
I R
IR
D000208:Acute Disease; D048909:Diabetes Complications; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D000077545:Eplerenone; D006333:Heart Failure / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D009203:Myocardial Infarction / Q000150:complications* / Q000188:drug therapy* / Q000401:mortality; D013148:Spironolactone / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives*; D016896:Treatment Outcome
D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000077545:Eplerenone
Effektivnost' blokatora retseptorov k al'dosteronu éplerenona u bol'nykh s ostrym infarktom miokarda s priznakami serdechnoĭ nedostatochnosti: rezul'taty issledovaniia EPHESUS.